Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. RBC Sees Johnson & Johnson (JNJ) Well Positioned to Manage Legal Overhang On February 3, RBC Capital raised its price target on Johnson & Johnson (NYSE:JNJ) to $255 from$240 and reiterated an Outperform rating. The firm said the company is unlikely to reverse the core implications of the Daubert ruling. Even so, the analyst noted that the litigation could stretch on for years, handled case by case and year ...